China's E-cigarette Export Market Analysis in First Half of 2024

Industry Insight by 2FIRSTS
Jul.24.2024
China's E-cigarette Export Market Analysis in First Half of 2024
China's e-cigarette exports in the first half of 2024 totaled $5.38 billion, showing a 1.82% drop from last year.

On July 24th, after the General Administration of Customs of China released the import and export data for June, the export data for e-cigarettes for the first half of 2024 (January to June) has been completed. 2FIRSTS compiled the data for January to June 2024, showing that the total export value of e-cigarettes in the first half of the year reached $5.381 billion, a 1.82% decrease compared to the same period last year, which was $5.481 billion.

China's E-cigarette Export Market Analysis in First Half of 2024
Half-year e-cigarette export data | Chart: 2FIRSTS


Export volume is increasing, but unit prices are decreasing.

China's E-cigarette Export Market Analysis in First Half of 2024
Half year e-cigarette export data | Chart by: 2FIRSTS


In the first half of 2024, despite showing a growth trend in export volume, the total export value decreased.

China's E-cigarette Export Market Analysis in First Half of 2024
Translation: E-cigarette export data for six months|Chart: 2FIRSTS


In the first half of 2024, China's e-cigarette exports reached 121,000 tons, compared to 104,200 tons in the same period last year, representing a year-on-year increase of approximately 16.12%.

China's E-cigarette Export Market Analysis in First Half of 2024
Data ranking | Map by: 2FIRSTS


The average export unit price is $44.54, a year-on-year decrease of approximately 16.23% compared to the same period last year, when it was $53.17.

China's E-cigarette Export Market Analysis in First Half of 2024
Data Ranking | Chart: 2FIRSTS


The United States emerges as a major growth engine, with the Middle East showing a significant increase in growth rates.


According to customs data, the top ten countries and regions for e-cigarette exports in the first half of the year are the United States, United Kingdom, South Korea, Germany, Russia, the Netherlands, Malaysia, Canada, Japan, and the United Arab Emirates. The top 8 rankings remain unchanged, with the Philippines and Australia dropping out of the top 10 (Australia declined by 90.12%, the Philippines by 25.69%), and the United Arab Emirates and Japan entering the top 10.


Furthermore, half of the countries experienced a year-on-year decline in growth rates, including the United Kingdom, South Korea, Germany, Malaysia, and Canada. Only the United States maintained a growth rate of over 10%, while the United Arab Emirates in the Middle East also saw close to a 10% growth rate.


It is worth noting that Australia and the Philippines, both countries which fell out of the top 10, have experienced increased enforcement actions by regulatory authorities against the e-cigarette industry in the first half of this year.


Countries such as New Zealand and South Africa have experienced growth rates exceeding 50%.


According to customs data, the top ten countries and regions with the highest export growth of e-cigarettes are Azerbaijan, Mexico, Israel, Greece, Mongolia, New Zealand, South Africa, Egypt, Ukraine, and Austria. Azerbaijan, Mexico, and Israel all saw growth rates exceeding 100%.


These countries are not long-term hot markets for e-cigarettes, but New Zealand and South Africa have reached sizes of 61.55 million US dollars and 50.89 million US dollars respectively, with year-on-year growth exceeding 50%.


In general, the first half of 2024 saw a trend in the Chinese e-cigarette export market of "increased quantity and decreased price", with total export value and unit price both decreasing, while export volume is on the rise. The main growth points continue to be the US and Middle East markets, while traditional markets such as the UK and Australia are experiencing slower growth or decline due to regulatory influences. At the same time, emerging markets like New Zealand and South Africa are showing strong performance, potentially indicating significant growth potential.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa plans to publish its first vapor products directory on November 16, 2026, after which products not listed will be prohibited from sale or offer for sale in the state. The Department of Revenue expects to begin penalty enforcement on December 17, following an initial 21-business-day period focused on compliance education. Under House File 2677, retailers, distributors and wholesalers selling unlisted products face civil penalties of $300 per product per day, while manufacturers face $1,000 per product per day. Eligibility extends to FDA-authorized products and certain products meeting historical marketing and pending PMTA requirements. The directory program resumed after a federal appeals court vacated a preliminary injunction in July 2026.
Regulations
Nov.05
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives said on September 23 that it has joined the interagency Trade Fraud Task Force to strengthen enforcement against illegal, misdeclared and smuggled vape and tobacco products. ATF will bring its authority under the Prevent All Cigarette Trafficking Act into the task force, including registration, reporting, shipping and record-inspection requirements covering interstate sales of electronic nicotine delivery systems. ATF said the move will strengthen its ability to trace illicit products from U.S. points of entry through domestic trafficking and distribution networks.
News
Sep.28 by 2Firsts Perspectives
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Global tobacco leaf markets diverged sharply in 2026, with India cutting authorised FCV production amid oversupply while Malawi faced a supply shortfall. U.S. demand improved in some leaf categories, but growers in Brazil, Colombia, Tanzania and Zimbabwe faced pressure from prices, buyer access, costs and weather. With nicotine consumption patterns also shifting, 2027 will test whether supply, demand and grower profitability can move back toward balance.
Oct.26
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09